Literature DB >> 20367206

Treatment of posterior fossa tumors in children.

Dattatraya Muzumdar1, Enrique C G Ventureyra.   

Abstract

The most common posterior fossa tumors in children are medulloblastoma, astrocytoma and ependymoma. Atypical rhabdoid teratoid tumors and brain stem gliomas are relatively rare. As the posterior fossa is a limited space, the tumors presenting in this region cause symptoms early on and require prompt treatment to avoid potential morbidity and mortality. Early detection and diagnosis of these tumors and prompt neurosurgical consultation is crucial in the optimum management of pediatric infratentorial brain tumors. Surgery is the mainstay of treatment, as it provides biopsy and decompression of the tumor. Adjuvant therapy is required in the majority of cases. Recent advances in the field of radiation biology and pharmacology have improved dose and delivery techniques of chemoradiation therapy. In the current era, advances in translational research and molecular genetics have assumed a major role in the pursuit of achieving a 'cure' for these potentially malignant tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367206     DOI: 10.1586/ern.10.28

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  10 in total

1.  Depressed skull fracture by a three-pin head holder: a case illustration.

Authors:  Dattatraya P Muzumdar
Journal:  Childs Nerv Syst       Date:  2011-05-28       Impact factor: 1.475

Review 2.  Executive dysfunction in pediatric posterior fossa tumor survivors: a systematic literature review of neurocognitive deficits and interventions.

Authors:  Kelly R Wolfe; Avi Madan-Swain; Rajesh K Kana
Journal:  Dev Neuropsychol       Date:  2012       Impact factor: 2.253

Review 3.  Radiomics and radiogenomics in pediatric neuro-oncology: A review.

Authors:  Rachel Madhogarhia; Debanjan Haldar; Sina Bagheri; Ariana Familiar; Hannah Anderson; Sherjeel Arif; Arastoo Vossough; Phillip Storm; Adam Resnick; Christos Davatzikos; Anahita Fathi Kazerooni; Ali Nabavizadeh
Journal:  Neurooncol Adv       Date:  2022-05-27

4.  The Satisfactory Surgical Outcome of Posterior Fossa Brain Tumors in Children at Civil Hospital, Karachi.

Authors:  Jahanzeb Kakar; Junaid Ashraf; Atiq Ahmed Khan; Muhammad Imran; Muhammad Asim Rehmani; Shiraz Ahmed Ghori; Mohammad Faaiq Ali
Journal:  Asian J Neurosurg       Date:  2020-05-29

5.  External drainage with an Ommaya reservoir for perioperative hydrocephalus in children with posterior fossa tumors.

Authors:  Changzhen Jiang; Xiyue Wu; Zhixiong Lin; Chenyang Wang; Dezhi Kang
Journal:  Childs Nerv Syst       Date:  2013-03-17       Impact factor: 1.475

6.  Risk factors for surgical site infection in pediatric posterior fossa tumors.

Authors:  Amparo Sáenz; Eugenia Badaloni; Miguel Grijalba; Juan F Villalonga; Romina Argañaraz; Beatriz Mantese
Journal:  Childs Nerv Syst       Date:  2021-06-17       Impact factor: 1.475

7.  Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients.

Authors:  Dattatraya Muzumdar; Amit Deshpande; Ratnesh Kumar; Ankur Sharma; Naina Goel; Nitin Dange; Abhida Shah; Atul Goel
Journal:  J Pediatr Neurosci       Date:  2011-10

8.  Ewing sarcoma of the posterior fossa in an adolescent girl.

Authors:  Andreas M Stark; Ivo Leuschner; H Maximilian Mehdorn; Alexander Claviez
Journal:  Case Rep Med       Date:  2014-12-29

9.  Postoperative pneumoventricle following posterior fossa tumor surgery in sitting position: Plugging the aqueduct.

Authors:  Dattatraya Muzumdar
Journal:  J Pediatr Neurosci       Date:  2020-03-19

Review 10.  Facing CAR T Cell Challenges on the Deadliest Paediatric Brain Tumours.

Authors:  Cristina Ferreras; Lucía Fernández; Laura Clares-Villa; Marta Ibáñez-Navarro; Carla Martín-Cortázar; Isabel Esteban-Rodríguez; Javier Saceda; Antonio Pérez-Martínez
Journal:  Cells       Date:  2021-10-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.